CompaniesEleusis

Eleusis

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

58

By Phase

PHASE4: 1PHASE1/PHASE2: 1

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
Today
NCT01982435
NCT02503540
Hover over trial bars to see details

Recent Trials

NCT02503540Lead Sponsor
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
PHASE4Completed
31 participants
Started: Aug 18, 2015 · Completed: Feb 6, 2018
NCT01982435Lead Sponsor
Safety and Efficacy of Ranibizumab for Diabetic Macular Edema
PHASE1/PHASE2Completed
27 participants
Started: Jun 24, 2014 · Completed: May 26, 2016
Funding History (3)
D/A
Jun 28, 2016
Filing
D
Jun 10, 2016
Filing
D
Feb 7, 2014
Filing
Related Companies
Beckley Psytech
acquired
Eleusis | Biotech Hunter | Biotech Hunter